EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Bone Substitute Material in the Surgical Therapy of Peri‐Implantitis—3‐Year Outcomes of a Randomized Controlled Trial

Lamija Alibegovic iD, Anna Trullenque-Eriksson iD, Alberto Ortiz-Vigón iD, Adrián Guerrero iD, Mauro Donati iD, Eriberto Bressan, Karolina Karlsson iD, Carlotta Dionigi iD, Erik Regidor iD, Yuki Ichioka, Cristiano Tomasi iD, Paolo Ghensi iD und 4 weitere

Clinical Oral Implants Research · 2025

DOI: 10.1111/clr.14393 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, 2025. Verfasst von Lamija Alibegovic und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Peri-Implantitis, Bone Substitutes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Osteology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the potential mid‐term benefit of the use of a bone substitute material in the reconstructive surgical treatment of peri‐implantitis.

Methods

A total of 120 subjects (127 implants) affected by peri‐implantitis were followed over 3 years in a multicenter randomized clinical trial. Participants had been randomized to either control (access flap surgery) or test group (access flap surgery and bone substitute material). Clinical, radiographic, and patient‐reported outcomes were assessed. The primary outcome was a composite measure including probing pocket depth ≤ 5 mm, absence of bleeding and suppuration on probing, soft tissue recession ≤ 1 mm, and implant neither reoperated nor lost. In an additional outcome (disease resolution), we allowed for one bleeding site and did not consider recession.

Results

While 14 implants (11%) were lost and a second surgical intervention had been performed at 3 implants (2.4%), pronounced improvements of clinical parameters were noted at remaining implants in both treatment groups at the 3‐year follow‐up. This was illustrated by a 3.2–3.5 mm reduction in probing pocket depth and a marginal bone level gain of 1.1–1.3 mm. The primary composite outcome, however, was only achieved at 14% of implants. The second composite outcome defining disease resolution was accomplished at 39% of implants. Patient‐reported outcomes were generally favorable.

Conclusion

At 3 years, the use of a bone substitute material in the surgical therapy of peri‐implantitis did not result in a clear benefit over access flap surgery alone. Trial Registration ClinicalTrials.gov identifier: NCT0307706

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peri-ImplantitisBone SubstitutesHumansMaleFemaleMiddle AgedTreatment OutcomeSurgical FlapsAgedPeriodontal IndexAdult

Stichwörter der Autor:innen

dental implantperi‐implantitisreconstructive therapysurgical therapy

Substanzen

Bone Substitutes

Autor:innen und Institutionen

  • Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Clínica Ortiz-Vigón, PerioCentrum, Bilbao, Spain.
  • ETEP Research Group, Faculty of Odontology, University Complutense of Madrid, Madrid, Spain.
  • Private Practice, Clínica Guerrero, Marbella, Spain.
  • Department of Neuroscience, Faculty of Odontology, University of Padua, Padua, Italy.
  • Clinic of Periodontics, Public Dental Service, Region Västra Götaland, Gothenburg, Sweden.

ORCID-Profile: Lamija Alibegovic, Anna Trullenque-Eriksson, Alberto Ortiz-Vigón, Adrián Guerrero, Mauro Donati, Karolina Karlsson, Carlotta Dionigi, Erik Regidor, Cristiano Tomasi, Paolo Ghensi, Ingemar Abrahamsson, Tord Berglundh, Jan Derks

Förderung

  • Osteology Foundation

Zitieren

APA

Alibegovic, L., Trullenque-Eriksson, A., Ortiz-Vigón, A., Guerrero, A., Donati, M., Bressan, E., Karlsson, K., Dionigi, C., Regidor, E., Ichioka, Y., Tomasi, C., Ghensi, P., Schaller, D., Abrahamsson, I., Berglundh, T., & Derks, J. (2025). Bone Substitute Material in the Surgical Therapy of Peri‐Implantitis—3‐Year Outcomes of a Randomized Controlled Trial. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14393

Vancouver

Alibegovic L, Trullenque-Eriksson A, Ortiz-Vigón A, Guerrero A, Donati M, Bressan E, et al. Bone Substitute Material in the Surgical Therapy of Peri‐Implantitis—3‐Year Outcomes of a Randomized Controlled Trial. Clinical Oral Implants Research. 2025. doi:10.1111/clr.14393

BibTeX
@article{Alibegovic2025,
  author = {Alibegovic, Lamija and Trullenque-Eriksson, Anna and Ortiz-Vigón, Alberto and Guerrero, Adrián and Donati, Mauro and Bressan, Eriberto and Karlsson, Karolina and Dionigi, Carlotta and Regidor, Erik and Ichioka, Yuki and Tomasi, Cristiano and Ghensi, Paolo and Schaller, Dennis and Abrahamsson, Ingemar and Berglundh, Tord and Derks, Jan},
  title = {Bone Substitute Material in the Surgical Therapy of Peri‐Implantitis—3‐Year Outcomes of a Randomized Controlled Trial},
  journal = {Clinical Oral Implants Research},
  year = {2025},
  doi = {10.1111/clr.14393}
}
Kostenlos starten →